259 related articles for article (PubMed ID: 12388585)
41. Immunodetection of disease-associated conformers of mutant cu/zn superoxide dismutase 1 selectively expressed in degenerating neurons in amyotrophic lateral sclerosis.
Sábado J; Casanovas A; Hernández S; Piedrafita L; Hereu M; Esquerda JE
J Neuropathol Exp Neurol; 2013 Jul; 72(7):646-61. PubMed ID: 23771221
[TBL] [Abstract][Full Text] [Related]
42. Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Andrus PK; Fleck TJ; Gurney ME; Hall ED
J Neurochem; 1998 Nov; 71(5):2041-8. PubMed ID: 9798929
[TBL] [Abstract][Full Text] [Related]
43. Adverse effects of a SOD1-peptide immunotherapy on SOD1 G93A mouse slow model of amyotrophic lateral sclerosis.
Sábado J; Casanovas A; Rodrigo H; Arqué G; Esquerda JE
Neuroscience; 2015 Dec; 310():38-50. PubMed ID: 26384962
[TBL] [Abstract][Full Text] [Related]
44. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Bryson JB; Hobbs C; Parsons MJ; Bosch KD; Pandraud A; Walsh FS; Doherty P; Greensmith L
Hum Mol Genet; 2012 Sep; 21(17):3871-82. PubMed ID: 22678056
[TBL] [Abstract][Full Text] [Related]
45. The omega-3 fatty acid eicosapentaenoic acid accelerates disease progression in a model of amyotrophic lateral sclerosis.
Yip PK; Pizzasegola C; Gladman S; Biggio ML; Marino M; Jayasinghe M; Ullah F; Dyall SC; Malaspina A; Bendotti C; Michael-Titus A
PLoS One; 2013; 8(4):e61626. PubMed ID: 23620776
[TBL] [Abstract][Full Text] [Related]
46. Ablation of interleukin-19 improves motor function in a mouse model of amyotrophic lateral sclerosis.
Komiya H; Takeuchi H; Ogawa Y; Suzuki K; Ogasawara A; Takahashi K; Azuma YT; Doi H; Tanaka F
Mol Brain; 2021 Apr; 14(1):74. PubMed ID: 33931083
[TBL] [Abstract][Full Text] [Related]
47. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.
Beqollari D; Romberg CF; Dobrowolny G; Martini M; Voss AA; Musarò A; Bannister RA
Skelet Muscle; 2016; 6():24. PubMed ID: 27340545
[TBL] [Abstract][Full Text] [Related]
48. Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord.
Olsen MK; Roberds SL; Ellerbrock BR; Fleck TJ; McKinley DK; Gurney ME
Ann Neurol; 2001 Dec; 50(6):730-40. PubMed ID: 11761470
[TBL] [Abstract][Full Text] [Related]
49. Assessment of metal concentrations in the SOD1
Enge TG; Ecroyd H; Jolley DF; Yerbury JJ; Kalmar B; Dosseto A
Mol Cell Neurosci; 2018 Apr; 88():319-329. PubMed ID: 29524628
[TBL] [Abstract][Full Text] [Related]
50. Zn II(atsm) is protective in amyotrophic lateral sclerosis model mice via a copper delivery mechanism.
McAllum EJ; Roberts BR; Hickey JL; Dang TN; Grubman A; Donnelly PS; Liddell JR; White AR; Crouch PJ
Neurobiol Dis; 2015 Sep; 81():20-4. PubMed ID: 25766674
[TBL] [Abstract][Full Text] [Related]
51. Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models.
Magrané J; Cortez C; Gan WB; Manfredi G
Hum Mol Genet; 2014 Mar; 23(6):1413-24. PubMed ID: 24154542
[TBL] [Abstract][Full Text] [Related]
52. Genetically decreased spinal cord copper concentration prolongs life in a transgenic mouse model of amyotrophic lateral sclerosis.
Kiaei M; Bush AI; Morrison BM; Morrison JH; Cherny RA; Volitakis I; Beal MF; Gordon JW
J Neurosci; 2004 Sep; 24(36):7945-50. PubMed ID: 15356208
[TBL] [Abstract][Full Text] [Related]
53. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
[TBL] [Abstract][Full Text] [Related]
54. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
[TBL] [Abstract][Full Text] [Related]
55. Biochemical properties and in vivo effects of the SOD1 zinc-binding site mutant (H80G).
Son M; Srikanth U; Puttaparthi K; Luther C; Elliott JL
J Neurochem; 2011 Sep; 118(5):891-901. PubMed ID: 21692800
[TBL] [Abstract][Full Text] [Related]
56. Impaired SDF1/CXCR4 signaling in glial progenitors derived from SOD1(G93A) mice.
Luo Y; Xue H; Pardo AC; Mattson MP; Rao MS; Maragakis NJ
J Neurosci Res; 2007 Aug; 85(11):2422-32. PubMed ID: 17567884
[TBL] [Abstract][Full Text] [Related]
57. Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis.
Hensley K; Floyd RA; Gordon B; Mou S; Pye QN; Stewart C; West M; Williamson K
J Neurochem; 2002 Jul; 82(2):365-74. PubMed ID: 12124437
[TBL] [Abstract][Full Text] [Related]
58. X-Linked inhibitor of apoptosis protein is involved in mutant SOD1-mediated neuronal degeneration.
Ishigaki S; Liang Y; Yamamoto M; Niwa J; Ando Y; Yoshihara T; Takeuchi H; Doyu M; Sobue G
J Neurochem; 2002 Aug; 82(3):576-84. PubMed ID: 12153481
[TBL] [Abstract][Full Text] [Related]
59. Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis.
Andreassen OA; Ferrante RJ; Klivenyi P; Klein AM; Shinobu LA; Epstein CJ; Beal MF
Ann Neurol; 2000 Apr; 47(4):447-55. PubMed ID: 10762155
[TBL] [Abstract][Full Text] [Related]
60. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
